This page shows the latest Mylotarg news and features for those working in and with pharma, biotech and healthcare.
The approval is also remarkable because it adds to the small stable of ADCs that have been approved for marketing, along with Pfizer’s Mylotarg (gemtuzumab ozogamicin) for acute myeloid leukaemia,
NICE has published draft guidance recommending Pfizer’s Mylotarg (gemtuzumab ozogamicin) in combination with chemotherapy for newly diagnosed de novo CD33-positive acute myeloid leukaemia (AML) – but only if the disease ... That means Mylotarg
Pfizer kept producing Mylotarg in order to make it available on compassionate use in Europe and this gave independent investigators the opportunity to continue to study the drug. ... If approved, the addition of Mylotarg to standard chemotherapy will
Also waiting in the wings could be volasertib from Boehringer Ingelheim, which is currently in phase III clinical trials, and Pifzer's Mylotarg, which would be reintroduced to the market after
Treatment options for AML are still somewhat limited, however at the end of last year Pfizer's Mylotarg (gemtuzumab ozogamcin) also showed itself to significantly improve overall survival compared to best
Pfizer kept producing Mylotarg in order to make it available on compassionate use grounds in Europe and this has given independent investigators the opportunity to continue to study the drug. ... We are engaging in discussions with the FDA and other
More from news
Approximately 2 fully matching, plus 10 partially matching documents found.
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...